Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

ILT2 identifies an unexploited pool of intratumoral CD8+ bystander T cells with TCR-independent cytotoxicity in renal cell carcinoma.

Cancer immunology research·2026
Same author

Cannabidiol modulates classical and non-classical hla expression in human choriocarcinoma cell line.

Human immunology·2026
Same author

Multicentre Validation of the 2019 Briganti Nomogram: One Threshold Does Not Fit All.

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same author

A single-centre assessment of short-term functional outcomes of holmium laser enucleation vs. robot-assisted simple prostatectomy for medium and large-volume benign prostatic hyperplasia.

The French journal of urology·2026
Same author

[Specificities of oncologic surgery in elder patients].

La Revue du praticien·2026
Same author

Single Center Experience of Femoral Surgical Cannulation for Kidney Procurement and Transplantation From Controlled Donation After Circulatory Death.

Clinical transplantation·2026

相关实验视频

Updated: Jun 11, 2025

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
08:27

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

14.7K

HLA-G新表达修改了控制瘤细胞系的遗传程序.

Diana Tronik-Le Roux1,2, Marina Daouya3,4, Isabelle Poras3,4

  • 1CEA Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives/Atomic Energy and Alternative Energies Agency, HIRD Hematology and Immunology Research Division, Saint-Louis Hospital, 1 Avenue Claude Vellefaux, 75010, Paris, France. diana.tronik@gmail.com.

Cancer immunology, immunotherapy : CII
|October 2, 2024
PubMed
概括

调查癌中的免疫检查点揭示了人类白细胞抗原-G (HLA-G) 改变了瘤发育,血管生成和线粒体. 这一发现提供了超越免疫反应的新治疗点,以改善患者的治疗结果.

关键词:
癌症标志物 癌症标志物在 HLA-G 的情况下.免疫检查站 免疫检查站对转录组进行分析.ccRCCCC 在线观看

更多相关视频

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

11.4K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

300

相关实验视频

Last Updated: Jun 11, 2025

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
08:27

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

14.7K
Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

11.4K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

300

科学领域:

  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学
  • 分子生物学分子生物学

背景情况:

  • 免疫疗法通过恢复免疫功能显示出癌症治疗的前景.
  • 瘤表达的免疫抑制分子 (IC) 可以限制治疗疗效,导致患者的生存率低下.
  • 了解IC新表达的分子机制对于推进癌症治疗方案至关重要.

研究的目的:

  • 在清细胞细胞癌 (ccRCC) 瘤细胞中研究免疫检查点人类白细胞抗原-G (HLA-G) 的新表达引起的修饰.
  • 阐明HLA-G在瘤进化中的作用,超出其已知的免疫功能.

主要方法:

  • 在ccRCC中由HLA-G新表达引发的基因表达变化的分析.
  • 通过CRISPR/Cas9进行基因编辑,以确认HLA-G在调节特定基因表达中的作用.
  • 研究的途径包括瘤发育,血管生成,流和线粒体动力学.

主要成果:

  • HLA-G显著修改了参与瘤发育,血管新生,流和线粒体动态的关键基因.
  • 通过使用CRISPR/Cas9.9,证实了HLA-G在调节ADAM-12,NCAM1和NRP1等基因中的参与.
  • 在瘤细胞内展示了HLA-G的多方面的作用,超出了其既定的免疫功能.

结论:

  • HLA-G在ccRCC瘤细胞生物学中发挥着重要作用,影响瘤进展的关键途径.
  • 这些发现揭示了HLA-G的新型非免疫功能,表明它是潜在的治疗点.
  • 对HLA-G及其在各种瘤中的相互作用伙伴的进一步研究可能会导致改善癌症治疗和患者的治疗结果.